» Articles » PMID: 14993275

Mutations Causing Childhood Ataxia with Central Nervous System Hypomyelination Reduce Eukaryotic Initiation Factor 2B Complex Formation and Activity

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 Mar 3
PMID 14993275
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Childhood ataxia with central nervous system hypomyelination (CACH), or vanishing white matter leukoencephalopathy (VWM), is a fatal brain disorder caused by mutations in eukaryotic initiation factor 2B (eIF2B). eIF2B is essential for protein synthesis and regulates translation in response to cellular stresses. We performed mutagenesis to introduce changes equivalent to 12 human CACH/VWM mutations in three subunits of the equivalent factor from yeast (Saccharomyces cerevisiae) and analyzed effects on cell growth, translation, and gene expression in response to stresses. None of the mutations is lethal or temperature sensitive, but almost all confer some defect in eIF2B function significant enough to alter growth or gene expression under normal or stress conditions. Biochemical analyses indicate that mutations analyzed in eIF2Balpha and -epsilon reduce the steady-state level of the affected subunit, while the most severe mutant tested, eIF2Bbeta(V341D) (human eIF2B(betaV316D)), forms complexes with reduced stability and lower eIF2B activity. eIF2Bdelta is excluded from eIF2Bbeta(V341D) complexes. eIF2B(betav341D) function can be rescued by overexpression of eIF2Bdelta alone. Our findings imply CACH/VWM mutations do not specifically impair responses to eIF2 phosphorylation, but instead cause protein structure defects that impair eIF2B activity. Altered protein folding is characteristic of other diseases, including cystic fibrosis and neurodegenerative disorders such as Huntington, Alzheimer's, and prion diseases.

Citing Articles

The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystonia.

Calakos N, Caffall Z J Clin Invest. 2024; 134(7).

PMID: 38557486 PMC: 10977992. DOI: 10.1172/JCI177833.


Surviving and Adapting to Stress: Translational Control and the Integrated Stress Response.

Wek R, Anthony T, Staschke K Antioxid Redox Signal. 2023; 39(4-6):351-373.

PMID: 36943285 PMC: 10443206. DOI: 10.1089/ars.2022.0123.


Regulation and function of elF2B in neurological and metabolic disorders.

Hanson F, Hodgson R, Ribeiro de Oliveira M, Allen K, Campbell S Biosci Rep. 2022; 42(6).

PMID: 35579296 PMC: 9208314. DOI: 10.1042/BSR20211699.


GTP binding to translation factor eIF2B stimulates its guanine nucleotide exchange activity.

Kershaw C, Jennings M, Cortopassi F, Guaita M, Al-Ghafli H, Pavitt G iScience. 2021; 24(12):103454.

PMID: 34877508 PMC: 8633983. DOI: 10.1016/j.isci.2021.103454.


Galactosaemia occurring in association with primary ovarian insufficiency, Addison's disease and chronic myeloid leukaemia.

Khoury B, Shakir M, Hoang T BMJ Case Rep. 2021; 14(8).

PMID: 34433538 PMC: 8388307. DOI: 10.1136/bcr-2021-244788.


References
1.
Gomez E, Pavitt G . Identification of domains and residues within the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2Bepsilon) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation. Mol Cell Biol. 2000; 20(11):3965-76. PMC: 85753. DOI: 10.1128/MCB.20.11.3965-3976.2000. View

2.
Leegwater P, Vermeulen G, Konst A, Naidu S, Mulders J, Visser A . Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter. Nat Genet. 2001; 29(4):383-8. DOI: 10.1038/ng764. View

3.
Dickinson J . Pathways of leucine and valine catabolism in yeast. Methods Enzymol. 2000; 324:80-92. DOI: 10.1016/s0076-6879(00)24221-3. View

4.
Wong K, Armstrong R, Gyure K, Morrison A, Rodriguez D, Matalon R . Foamy cells with oligodendroglial phenotype in childhood ataxia with diffuse central nervous system hypomyelination syndrome. Acta Neuropathol. 2000; 100(6):635-46. DOI: 10.1007/s004010000234. View

5.
Kaye E . Update on genetic disorders affecting white matter. Pediatr Neurol. 2001; 24(1):11-24. DOI: 10.1016/s0887-8994(00)00232-0. View